查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434652

自體免疫疾病診斷市場：按類型、適應症、測試、產品和最終用戶分類 - 全球預測 2024-2030

Autoimmune Disease Diagnostics Market by Type (Localized Autoimmune Disease Diagnostics, Systemic Autoimmune Disease Diagnostics), Indication (Addison Disease, Celiac Disease, Dermatomyositis), Test, Product, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

自體免疫疾病診斷市場規模預計2023年為50.8億美元，2024年達到55.3億美元，預計2030年將達到93.3億美元，複合年成長率為9.06%。

自體免疫疾病診斷的全球市場

主要市場統計
基準年[2023] 50.8億美元
預測年份 [2024] 55.3億美元
預測年份 [2030] 93.3億美元
複合年成長率（%） 9.06%
自體免疫疾病診斷市場-IMG1

FPNV定位矩陣

FPNV 定位矩陣對於評估自體免疫疾病診斷市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對自體自體免疫疾病診斷市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-自體自體免疫疾病診斷市場的市場規模和預測是多少？

2-在自體自體免疫疾病診斷市場的預測期內，需要考慮投資的產品、細分市場、應用和領域有哪些？

3-自體自體免疫疾病診斷市場的技術趨勢和法律規範是什麼？

4-自體自體免疫疾病診斷市場主要供應商的市場佔有率是多少？

5-進入自體自體免疫疾病診斷市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 類風濕性關節炎、格雷夫茲病和橋本甲狀腺炎等自體自體免疫疾病的發生率增加
      • 關於自體自體免疫疾病的公眾意識和首選政府舉措
      • 改進的檢測技術和自動化
    • 抑制因素
      • 假陽性結果頻繁發生
      • 診斷測試週轉時間很慢
    • 機會
      • 採用生物感測器診斷自體免疫疾病
      • 醫生和臨床實驗室之間的策略夥伴關係
      • 試劑租賃協議和合作活動的潛在成長潛力
    • 任務
      • 與診斷過程相關的費用
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章自體免疫疾病診斷市場：按類型

  • 局部自體自體免疫疾病診斷
  • 自體免疫疾病診斷劑

第7章依適應症分類的自體免疫疾病診斷市場

  • 愛迪生氏症
  • 乳糜瀉
  • 皮肌炎
  • 格雷夫茲病
  • 橋本氏甲狀腺炎
  • 多發性硬化症
  • 重症肌無力
  • 惡性貧血
  • 反應性關節炎
  • 類風濕性關節炎
  • 修格蘭氏症候群
  • 全身性紅斑性狼瘡
  • I型糖尿病

第8章自體免疫疾病診斷市場測試

  • 自體抗體和免疫學測試
    • 抗環瓜胜肽
    • 抗核抗體
    • C反應蛋白
    • 紅血球沉積速率
    • 類風濕因子
    • 甲狀腺抗體測試
      • T3
      • T3RU
      • T4
      • TSH
  • 發炎標記物
  • 定期臨床檢查

第9章自體免疫疾病診斷市場：依產品

  • 耗材和檢測套件
  • 診斷設備

第10章自體免疫疾病診斷市場：依最終用戶分類

  • 臨床實驗室
  • 醫院

第11章 北美和南美自體免疫疾病診斷藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區自體免疫疾病診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲自體免疫疾病診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第15章競爭組合

  • 主要公司簡介
    • Abbott Laboratories
    • AESKU.GROUP GmbH & Co. KG
    • AstraZeneca PLC
    • Beckman Coulter, Inc.
    • Bio-Rad Laboratories, Inc.
    • BioAgilytix Labs
    • Biogenuix Medsystems Private Limited
    • bioMerieux SA
    • EUROIMMUN Medical Laboratory Diagnostics AG
    • Exagen Inc.
    • F. Hoffmann-La Roche AG
    • Hemagen Diagnostics, Inc.
    • Novartis AG
    • Pfizer Inc.
    • Quest Diagnostics
    • Sanofi SA
    • SD BioSensor Inc.
    • Siemens Healthineers AG
    • SQI Diagnostics
    • Thermo Fisher Scientific Inc.
    • Trinity Biotech PLC
    • Werfen Group
  • 主要產品系列

第16章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-436901065F43

[192 Pages Report] The Autoimmune Disease Diagnostics Market size was estimated at USD 5.08 billion in 2023 and expected to reach USD 5.53 billion in 2024, at a CAGR 9.06% to reach USD 9.33 billion by 2030.

Global Autoimmune Disease Diagnostics Market

KEY MARKET STATISTICS
Base Year [2023] USD 5.08 billion
Estimated Year [2024] USD 5.53 billion
Forecast Year [2030] USD 9.33 billion
CAGR (%) 9.06%
Autoimmune Disease Diagnostics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Autoimmune Disease Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Autoimmune Disease Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Autoimmune Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AESKU.GROUP GmbH & Co. KG, AstraZeneca PLC, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, Biogenuix Medsystems Private Limited, bioMerieux SA, EUROIMMUN Medical Laboratory Diagnostics AG, Exagen Inc., F. Hoffmann-La Roche AG, Hemagen Diagnostics, Inc., Novartis AG, Pfizer Inc., Quest Diagnostics, Sanofi S.A., SD BioSensor Inc., Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and Werfen Group.

Market Segmentation & Coverage

This research report categorizes the Autoimmune Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Localized Autoimmune Disease Diagnostics
    • Systemic Autoimmune Disease Diagnostics
  • Indication
    • Addison Disease
    • Celiac Disease
    • Dermatomyositis
    • Graves Disease
    • Hashimoto Thyroiditis
    • Multiple Sclerosis
    • Myasthenia Gravis
    • Pernicious Anemia
    • Reactive Arthritis
    • Rheumatoid Arthritis
    • Sjogren syndrome
    • Systemic Lupus Erythematosus
    • Type I Diabetes
  • Test
    • Autoantibodies & Immunologic Test
      • Anti-cyclic Citrullinated Peptide
      • Antinuclear Antibody
      • C-reactive Protein
      • Erythrocyte Sedimentation Rate
      • Rheumatoid Factor
      • Thyroid Antibody Tests
        • T3
        • T3RU
        • T4
        • TSH
    • Inflammatory Marker
    • Routine Laboratory Test
  • Product
    • Consumable & Assay Kit
    • Diagnostic Instrument
  • End User
    • Clinical Laboratory
    • Hospital
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Autoimmune Disease Diagnostics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Autoimmune Disease Diagnostics Market?

3. What are the technology trends and regulatory frameworks in the Autoimmune Disease Diagnostics Market?

4. What is the market share of the leading vendors in the Autoimmune Disease Diagnostics Market?

5. Which modes and strategic moves are suitable for entering the Autoimmune Disease Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Autoimmune Disease Diagnostics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Incidence of Autoimmune Diseases such as Rheumatoid Arthritis, Graves' disease and Hashimoto's thyroiditis
      • 5.1.1.2. Awareness Among Public About Autoimmune Diseases and Favorable Government Initiatives
      • 5.1.1.3. Improved Laboratory Techniques and Automation
    • 5.1.2. Restraints
      • 5.1.2.1. High Frequency of False Positive Results
      • 5.1.2.2. Slow Turnaround Time for Diagnostic Test
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of Biosensors for Autoimmune Disease Diagnosis
      • 5.1.3.2. Strategic Partnerships Between Physicians and Clinical Laboratories
      • 5.1.3.3. Potential Growth in Reagent Rental Agreements and Collaboration Activities
    • 5.1.4. Challenges
      • 5.1.4.1. Cost associated with the diagnosis process
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Autoimmune Disease Diagnostics Market, by Type

  • 6.1. Introduction
  • 6.2. Localized Autoimmune Disease Diagnostics
  • 6.3. Systemic Autoimmune Disease Diagnostics

7. Autoimmune Disease Diagnostics Market, by Indication

  • 7.1. Introduction
  • 7.2. Addison Disease
  • 7.3. Celiac Disease
  • 7.4. Dermatomyositis
  • 7.5. Graves Disease
  • 7.6. Hashimoto Thyroiditis
  • 7.7. Multiple Sclerosis
  • 7.8. Myasthenia Gravis
  • 7.9. Pernicious Anemia
  • 7.10. Reactive Arthritis
  • 7.11. Rheumatoid Arthritis
  • 7.12. Sjogren syndrome
  • 7.13. Systemic Lupus Erythematosus
  • 7.14. Type I Diabetes

8. Autoimmune Disease Diagnostics Market, by Test

  • 8.1. Introduction
  • 8.2. Autoantibodies & Immunologic Test
    • 8.3.1. Anti-cyclic Citrullinated Peptide
    • 8.3.2. Antinuclear Antibody
    • 8.3.3. C-reactive Protein
    • 8.3.4. Erythrocyte Sedimentation Rate
    • 8.3.5. Rheumatoid Factor
    • 8.3.6. Thyroid Antibody Tests
      • 8.3.7.1. T3
      • 8.3.7.2. T3RU
      • 8.3.7.3. T4
      • 8.3.7.4. TSH
  • 8.3. Inflammatory Marker
  • 8.4. Routine Laboratory Test

9. Autoimmune Disease Diagnostics Market, by Product

  • 9.1. Introduction
  • 9.2. Consumable & Assay Kit
  • 9.3. Diagnostic Instrument

10. Autoimmune Disease Diagnostics Market, by End User

  • 10.1. Introduction
  • 10.2. Clinical Laboratory
  • 10.3. Hospital

11. Americas Autoimmune Disease Diagnostics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Autoimmune Disease Diagnostics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Autoimmune Disease Diagnostics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Abbott Laboratories
    • 15.1.2. AESKU.GROUP GmbH & Co. KG
    • 15.1.3. AstraZeneca PLC
    • 15.1.4. Beckman Coulter, Inc.
    • 15.1.5. Bio-Rad Laboratories, Inc.
    • 15.1.6. BioAgilytix Labs
    • 15.1.7. Biogenuix Medsystems Private Limited
    • 15.1.8. bioMerieux SA
    • 15.1.9. EUROIMMUN Medical Laboratory Diagnostics AG
    • 15.1.10. Exagen Inc.
    • 15.1.11. F. Hoffmann-La Roche AG
    • 15.1.12. Hemagen Diagnostics, Inc.
    • 15.1.13. Novartis AG
    • 15.1.14. Pfizer Inc.
    • 15.1.15. Quest Diagnostics
    • 15.1.16. Sanofi S.A.
    • 15.1.17. SD BioSensor Inc.
    • 15.1.18. Siemens Healthineers AG
    • 15.1.19. SQI Diagnostics
    • 15.1.20. Thermo Fisher Scientific Inc.
    • 15.1.21. Trinity Biotech PLC
    • 15.1.22. Werfen Group
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 7. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 12. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 14. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 9. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ADDISON DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CELIAC DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DERMATOMYOSITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY GRAVES DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HASHIMOTO THYROIDITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PERNICIOUS ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REACTIVE ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SJOGREN SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE I DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 23. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 25. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTI-CYCLIC CITRULLINATED PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTINUCLEAR ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY C-REACTIVE PROTEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ERYTHROCYTE SEDIMENTATION RATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 32. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3RU, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T4, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TSH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INFLAMMATORY MARKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ROUTINE LABORATORY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLE & ASSAY KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 171. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 178. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 193. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 200. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 207. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 214. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 221. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 228. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 235. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 242. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 248. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 249. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 256. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 263. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 270. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 277. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 278. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 284. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 297. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 298. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 304. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 305. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 306. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 311. SWIT